What are the long-term malignancy risks with immunotherapies in MS?

When considering the long-term malignancy risks associated with immunotherapies in multiple sclerosis (MS), it’s crucial to understand both the nature of MS and the mechanisms of immunotherapy. Multiple sclerosis is an autoimmune disease where the immune system mistakenly attacks the…








